SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Mar 26, 2020

AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: March 26, 2020 · CIK: 0000882291 · Accession: 0001683168-20-000961

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-237269

Date
March 26, 2020
Author
Aethlon
Form
CORRESP
Company
AETHLON MEDICAL INC (AEMD) (CIK 0000882291)

Letter

Aethlon Medical, Inc.

9635 Granite Ridge Drive, Suite 100

San Diego, California 92123

March 26, 2020

Via Edgar

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Irene Paik

Re: Aethlon Medical, Inc. (the “Company”)

Registration Statement on Form S-3 (File No. 333-237269)

Acceleration Request

Requested Date: March 30, 2020

Requested Time: 4:15 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:15 P.M. Eastern Time on March 30, 2020, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact Julie Robinson of Cooley LLP at (858) 550-6092. Thank you for your assistance with this matter.

Very truly yours,
Aethlon
medical, Inc.

Show Raw Text
CORRESP
1
filename1.htm

Aethlon Medical, Inc.

9635 Granite Ridge Drive, Suite 100

San Diego, California 92123

March 26, 2020

Via
Edgar

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn:          Irene Paik

    Re:
    Aethlon Medical, Inc. (the “Company”)

    Registration Statement on Form S-3 (File No. 333-237269)

Acceleration Request

    Requested Date:
    March 30, 2020

    Requested Time:
    4:15 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities
Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”)
take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:15 P.M. Eastern
Time on March 30, 2020, or as soon thereafter as is practicable.

If you have any questions regarding this
request, please contact Julie Robinson of Cooley LLP at (858) 550-6092. Thank you for your assistance with this matter.

Very truly yours,

Aethlon
medical, Inc.

/s/ James B. Frakes

James B. Frakes

Chief Financial Officer